鉄依存性細胞分解の誘導物質との併用抗癌療法 - Flagship Pioneering Innovations Buoy, Inc.

Title:

鉄依存性細胞分解の誘導物質との併用抗癌療法

Document Type and Number:

Japanese Patent JP2023509359

Kind Code:

A

Abstract:

本発明は、（ａ）抗腫瘍剤と（ｂ）鉄依存性細胞分解を誘導する薬剤の組み合わせを対象に投与し、それにより対象の癌を処置することを含む、対象の癌を処置する方法を提供する。いくつかの実施形態では、癌は、抗腫瘍剤に耐性がある。【選択図】なし

More Like This:

JPH10500423	INDUSTRIAL APPLICABILITY: Drug compositions containing opiate antagonists and calcium salts, their use for the treatment of endorphin-mediated medical conditions.
WO/2005/049030	COMBINATION THERAPY COMPRISING THE USE OF ET-743 AND PACLITAXEL FOR TREATING CANCER
JP2008512486	Combination of organic compounds

Inventors:

Versotti, Antony, Michael
Country, Alexandra, Mass
Park, jason
Schmidt, Derby, Rye
Goff, Peter, Joseph

Application Number:

JP2022536952A

Publication Date:

March 08, 2023

Filing Date:

December 17, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Flagship Pioneering Innovations Buoy, Inc.

International Classes:

A61K45/06; A61K31/381; A61K31/437; A61K31/506; A61K31/517; A61K45/00; A61K47/68; A61P1/00; A61P11/00; A61P15/00; A61P17/00; A61P35/00; A61P35/02; A61P37/04; A61P43/00

Attorney, Agent or Firm:

Patent Attorney Corporation Hiraki International Patent Office

Previous Patent: Breath analysis method

Next Patent: Synthesis of compounds that promote hair growth